Bioanalysis ZONE | De-Risking mRNA-LNP Therapeutics Through Integrated DMPK, Bioanalysis, and Toxicology

From delivery to safety: integrated strategies for mRNA-LNP preclinical development.

mRNA-LNP therapeutics present unique preclinical development challenges related to delivery, biodistribution, bioanalysis and safety. This webinar will explore how integrated DMPK, bioanalytical and toxicology strategies can help characterize the disposition of mRNA-LNP components, measure relevant analytes and expressed proteins, and interpret exposure in the context of safety.

Attendees will gain practical insights into how to connect biodistribution, expression, and toxicology findings to support informed IND-enabling decisions.